Diagnostics Research Group Collaborates with Biogenics Research Chamber for Ragweed Study
New ragweed study is collaboration between Diagnostics Research Group and Biogenics Research Chamber.
San Antonio, TX (PRWEB) April 15, 2014
San Antonio and the surrounding areas are some of the worst places for allergies. Chronic allergy sufferers know that mountain cedar is prevalent during the winter months, oak during the spring, grass during the summer and ragweed during the fall, and that’s just to name a few. Chronic allergy sufferers also know that there seem to be new products on the market every year to help alleviate allergy symptoms, but how could researchers possibly get all of their work completed when they have a small window of time and are dependent on nature?
Until recently, researchers waited until the natural season of an allergen to study its effect on the general population, but now a group of doctors has opened a unique testing facility right here in San Antonio. The Biogenics Research Chamber is a facility where researchers can study the effects of many different types of allergens year round, regardless of their natural season. It is the only large permanent allergen exposure chamber in the United States and is designed to conduct allergic and non-allergic exposure studies in a controlled environment that utilizes clean room technology.
Essentially, researchers are able to take a group of participants who are allergic to a specific allergen, place them in an exposure chamber and study the effectiveness of a new treatment being developed by a pharmaceutical company. Diagnostics Research Group and Biogenics Research Group are collaborating on a study testing people who are allergic to ragweed. Participants need to be 18 years or older and have eye redness associated with ragweed allergies. Qualified participants may receive study-related medication, a study-related physical and eye exam at no cost and compensation up to $1,500.
Those interested in participating in the study can find out if they qualify by calling Diagnostics Research Group today at 210-692-7157 to schedule a free skin test or visit their website at http://www.dxrg.com/ for more information.
About Biogenics Research Chamber:
Dr. Robert L. Jacobs, Dr. Daniel A. Ramirez and Dr. Charles P. Andrews are the owners and Principal Investigators of the Biogenics Research Chamber located in San Antonio, Texas. The facility has challenge chambers designed to conduct allergic and non-allergic exposure studies in a controlled environment that utilizes clean room technology. The facility has been validated for four pollens and for dust mites. Proof of concept, dose-ranging and onset of action studies are performed for pharmaceutical and vaccine trials. Academic studies are performed to discover the basic immunologic mechanisms associated with allergic disorders. For companies investigating new products, the chambers offer the advantage of concentrating project resources with the potential to shorten medication and vaccine development times.
About Diagnostics Research Group:
Diagnostics Research Group, located in the South Texas Medical Center in San Antonio, Texas, is an independent clinical research site that performs research studies to test the safety and effectiveness of new drugs, treatments and medical devices.
Patients who volunteer for clinical studies are helping the advancement of medicine with no cost to the participants. Once enrolled in a study, the patient will receive compensation for time and travel. Free health screenings are also available, which include: allergy, blood pressure, blood sugar, breathing and cholesterol tests.
Those interested in volunteering for clinical trials can expect quality care from the staff at Diagnostics Research Group. Nine staff members are certified by the Association of Clinical Research Professionals. Diagnostics Research Group has research experience with more than 200 studies, including allergy studies, asthma studies and COPD studies. Other several therapeutic areas include: cedar allergy, respiratory diseases, internal medicine, women’s health, vaccines and sleep disorders. For more information, please visit their website.
For the original version on PRWeb visit: http://www.prweb.com/releases/Clinical-Studies/Asthma-Studies/prweb11766450.htm